Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by1H-NMR-based metabonomics

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 2, 2010, Pages

  Hwang, Geum Sook ^a,b   Yang, Ji Young ^a,b   Ryu, Do Hyun ^c   Kwon, Tae Hwan ^d  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Chungnam National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

Author keywords

Multivariate analysis; NMR spectroscopy; Urinary concentration

Indexed keywords

ACETIC ACID; ALLANTOIN; AMINO ACID DERIVATIVE; BETAINE; CREATINE; GLUCOSE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; LITHIUM; TAURINE; TRIMETHYLAMINE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMICS; CELL STRESS; CONTROLLED STUDY; GLYCOLYSIS; KIDNEY CORTEX; KIDNEY HOMOGENATE; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY METABOLISM; KIDNEY PARENCHYMA; MALE; METABOLITE; METABONOMICS; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; URINE;

EID: 75149193497     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00389.2009     Document Type: Article

References (47)

1. Aurell M, Svalander C, Wallin L, Alling C. Renal function and biopsy findings in patients on long-term lithium treatment. Kidney Int 20: 663-670, 1981.
2. Backshall A, Alferez D, Teichert F, Wilson ID, Wilkinson RW, Goodlad RA, Keun HC. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy. J Proteome Res 8: 1423-1430, 2009.
3. Barba I, Fernandez-Montesinos R, Garcia-Dorado D, Pozo D. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. J Cell Mol Med 12: 1477-1485, 2008.
4. Baverel G, Conjard A, Chauvin MF, Vercoutere B, Vittorelli A, Dubourg L, Gauthier C, Michoudet C, Durozard D, Martin G. Carbon 13 NMR spectroscopy: a powerful tool for studying renal metabolism. Biochimie 85: 863-871, 2003.
5. Bedford JJ, Leader JP, Jing R, Walker LJ, Klein JD, Sands JM, Walker RJ. Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 294: F812-F820, 2008.
6. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10: 329-345, 1987.
7. Brandish PE, Su M, Holder DJ, Hodor P, Szumiloski J, Kleinhanz RR, Forbes JE, McWhorter ME, Duenwald SJ, Parrish ML, Na S, Liu Y, Phillips RL, Renger JJ, Sankaranarayanan S, Simon AJ, Scolnick EM. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron 45: 861-872, 2005.
8. 1H-NMR-based metabonomics. Nat Med 8: 1439-1444, 2002.
9. Christensen BM, Kim YH, Kwon TH, Nielsen S. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. Am J Physiol Renal Physiol 291: F39-F48, 2006.
10. Christensen EI, Nielsen S. Structural and functional features of protein handling in the kidney proximal tubule. Semin Nephrol 11: 414-439, 1991.
11. Coen M, Holmes E, Lindon JC, Nicholson JK. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 21: 9-27, 2008.
12. Dimari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol Renal Physiol 272: F292-F298, 1997.
13. Domanski L, Safranow K, Dolegowska B, Rozanski J, Myslak M, Ciechanowski K, Jakubowska K, Dziedziejko V, Romanowski M, Sulikowski T, Sienko J, Kaminski M, Ostrowski M, Domanski M, Pawlik A, Rac ME, Chlubek D. Hypoxanthine as a graft ischemia marker stimulates catalase activity in the renal vein during reperfusion in humans. Transplant Proc 38: 35-38, 2006.
14. Dunn WB, Bailey NJ, Johnson HE. Measuring the metabolome: current analytical technologies. Analyst 130: 606-625, 2005.
15. Efrati S, Averbukh M, Berman S, Feldman L, Dishy V, Kachko L, Weissgarten J, Golik A, Averbukh Z. N-Acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrol Dial Transplant 20: 65-70, 2005.
16. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, Lazzeri G, Spalloni A, Bellio N, Lenzi P, Modugno N, Siciliano G, Isidoro C, Murri L, Ruggieri S, Paparelli A. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 105: 2052-2057, 2008.
17. Garcia-Perez A, Burg MB. Renal medullary organic osmolytes. Physiol Rev 71: 1081-1115, 1991.
18. Harrell NB, Teachey MK, Gifford NJ, Henriksen EJ. Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium. Arch Physiol Biochem 113: 221-227, 2007.
19. Hauet T, Baumert H, Gibelin H, Hameury F, Goujon JM, Carretier M, Eugene M. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology 41: 280-291, 2000.
20. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-400, 2008.
21. Kind T, Tolstikov V, Fiehn O, Weiss RH. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363: 185-195, 2007.
22. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459, 1996.
23. + transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol 279: F552-F564, 2000.
24. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9: 1-31, 2004.
25. Madsen KM, Verlander JW, Tisher CC. Relationship between structure and function in distal tubule and collecting duct. J Electron Microsc Tech 9: 187-208, 1988.
26. Majerus PW. Inositol phosphate biochemistry. Annu Rev Biochem 61: 225-250, 1992.
27. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95: 1838-1845, 1995.
28. Mayersohn M, Conrad KA, Achari R. The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance. Br J Clin Pharmacol 15: 227-230, 1983.
29. McAuliffe WG, Olesen OV. Effects of lithium on the structure of the rat kidney. Nephron 34: 114-124, 1983.
30. Nicholls AW, Holmes E, Lindon JC, Shockcor JP, Farrant RD, Haselden JN, Damment SJ, Waterfield CJ, Nicholson JK. Metabonomic investigations into hydrazine toxicity in the rat. Chem Res Toxicol 14: 975-987, 2001.
31. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 455: 1054-1056, 2008.
32. Nielsen J, Kwon TH, Christensen BM, Frøkiær J, Nielsen S. Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus. Semin Nephrol 28: 227-244, 2008.
33. Nielsen J, Kwon TH, Praetorius J, Kim YH, Frøkiær J, Knepper MA, Nielsen S. Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI. Am J Physiol Renal Physiol 285: F1198-F1209, 2003.
34. Schmid H, Henger A, Kretzler M. Molecular approaches to chronic kidney disease. Curr Opin Nephrol Hypertens 15: 123-129, 2006.
35. Schmolke M, Bornemann A, Guder WG. Site-specific regulation of organic osmolytes along the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 271: F645-F652, 1996.
36. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 67: 1142-1151, 2005.
37. Sherman WR, Gish BG, Honchar MP, Munsell LY. Effects of lithium on phosphoinositide metabolism in vivo. Fed Proc 45: 2639-2646, 1986.
38. Slupsky CM, Cheypesh A, Chao DV, Fu H, Rankin KN, Marrie TJ, Lacy P. Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses. J Proteome Res 8: 3029-3036, 2009.
39. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykes BD, Marrie TJ. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79: 6995-7004, 2007.
40. Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol 10: 666-674, 1999.
41. Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Gunther UL. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. PLoS One 4: e4251, 2009.
42. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemon 16: 119-128, 2002.
43. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78: 4430-4442, 2006.
44. Wishart DS. Metabolomics: the principles and potential applications to transplantation. Am J Transplant 5: 2814-2820, 2005.
45. Wishart DS. Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 15: 637-642, 2006.
46. Xia Y, Wen HY, Young ME, Guthrie PH, Taegtmeyer H, Kellems RE. Mammalian target of rapamycin and protein kinase A signaling mediate the cardiac transcriptional response to glutamine. J Biol Chem 278: 13143-13150, 2003.
47. Yap IK, Clayton TA, Tang H, Everett JR, Hanton G, Provost JP, Le Net JL, Charuel C, Lindon JC, Nicholson JK. An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J Proteome Res 5: 2675-2684, 2006.